University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
NCT Number: NCT00585702
The purpose of this study is to learn about the effects of bipolar disorder or the use of antimanic medications on the mother's health and wellbeing during pregnancy and for the first postpartum year. Infant health and development are also assessed during the first year. Participation in the study includes 7 study visits, three in pregnancy and four postpartum.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Pittsburgh, Pennsylvania, 15260, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Bipolar Subjects:
Inclusion criteria
for non-Bipolar Control Subject:
Exclusion criteria
for all:
Additional Exclusion Criteria for Control Subjects:
Time frame: 20, 30 36 weeks gestation, 2,12,28,52 weeks postpartum
Time frame: 20, 30 36 weeks gestation, 2,12,28,52 weeks postpartum
Time frame: 12, 28, 52 weeks postpartum
Time frame: 20,30,36 weeks gestation
Time frame: 20 weeks gestation at enrollment
Time frame: 20, 30 36 weeks gestation, 2,12,28,52 weeks postpartum
Time frame: 2, 12, 28, 52 weeks postpartum
Time frame: 2,12,28,52 weeks post delivery
University of Pittsburgh
Other
Acronym: AMUP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00864370
Bipolar Disorder, Bipolar and Related Disorders
Atlanta, Georgia, United States
View Trial DetailsNCT06365021
Bipolar Disorder, Bipolar and Related Disorders
São Paulo, Brazil
View Trial DetailsNCT02481245
Bipolar Disorder, Bipolar and Related Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial Details